CRISPR Therapeutics AG (CRSP) › Shares OutstandingCRISPR Therapeutics AG (CRSP) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2015: 5.53M2016: 39.72M2017: 40.59M2018: 51.85M2019: 60.78M2020: 73.91M2021: 76.99M2022: 78.51M2023: 80.04M2024: 85.74M2025: 95.89M95.89M2015Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202595.89M+11.8%202485.74M+7.1%202380.04M+2.0%202278.51M+2.0%202176.99M+4.2%202073.91M+21.6%201960.78M+17.2%201851.85M+27.7%201740.59M+2.2%201639.72M+618.5%20155.53M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share